paclitaxel has been researched along with ST Elevation Myocardial Infarction in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, M; Li, J; Qi, W; Wang, Z; Xu, Z; Yang, F; Yin, Y; Yu, B; Zhang, H; Zhu, W | 1 |
| Bhalraam, U; Corballis, N; Eccleshall, SC; Gilbert, T; Gunawardena, T; Maart, C; Mamas, MA; Merinopoulos, I; Mohamed, MO; Perperoglou, A; Reinhold, J; Richardson, P; Ryding, A; Sarev, T; Sawh, C; Sulfi, S; Vassiliou, VS; Wickramarachchi, U; Wistow, T | 1 |
| Ben-Yehuda, O; Brener, SJ; Ertelt, K; McAndrew, T; Mehran, R; Stone, GW | 1 |
| Baber, U; Camenzind, E; Chieffo, A; Dangas, GD; Faggioni, M; Farhan, S; Galatius, S; Giustino, G; Harari, R; Itchhaporia, D; Jeger, RV; Kandzari, D; Kastrati, A; Kim, HS; Kimura, T; Leon, MB; Mehran, R; Mehta, L; Morice, MC; Sartori, S; Serruys, PW; Sharma, M; Smits, PC; Sorrentino, S; Stefanini, GG; Steg, PG; Stone, GW; Valgimigli, M; Von Birgelen, C; Weisz, G; Wijns, W; Windecker, S | 1 |
| Eränen, J; Kärkkäinen, JM; Mäntylä, P; Mustonen, J; Rissanen, TT; Siljander, A; Uskela, S | 1 |
| Amoroso, G; Fagel, ND; Herrman, JR; Patterson, MS; Piers, LH; Slagboom, T; van der Schaaf, RJ; Vink, MA; Vos, NS | 1 |
| Amoroso, G; Herrman, JP; Patterson, MS; Slagboom, T; van der Schaaf, RJ; Vink, MA; Vos, NS | 1 |
| Ishikawa, T; Miyamoto, T; Mutoh, M; Nakano, Y | 1 |
| Baber, U; Clemmensen, P; Dangas, GD; Feit, F; Gersh, BJ; Guagliumi, G; Mehran, R; Ohman, EM; Pocock, SJ; Schoos, MM; Stone, GW; Witzenbichler, B; Yu, J | 1 |
6 trial(s) available for paclitaxel and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
New Ultrasound-Controlled Paclitaxel Releasing Balloon vs. Asymmetric Drug-Eluting Stent in Primary ST-Segment Elevation Myocardial Infarction - A Prospective Randomized Trial.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Treatment Outcome | 2022 |
Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI.
Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Drug-Eluting Stents; Humans; Paclitaxel; ST Elevation Myocardial Infarction; Treatment Outcome | 2023 |
Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
Topics: Aged; Cause of Death; Diabetes Mellitus; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Heparin; Hirudins; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Paclitaxel; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Period; Prognosis; Recombinant Proteins; ST Elevation Myocardial Infarction; Survival Rate; Time Factors; Treatment Outcome; United States | 2017 |
Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Drug-Eluting Stents; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Prospective Studies; Prosthesis Design; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2019 |
REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
Topics: Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Clinical Protocols; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Echocardiography; Fractional Flow Reserve, Myocardial; Humans; Netherlands; Paclitaxel; Prospective Studies; Prosthesis Design; Recurrence; Research Design; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2016 |
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes.
Topics: Aged; Antineoplastic Agents, Phytogenic; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Heparin; Hospital Mortality; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; New South Wales; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Sex Distribution; Sex Factors; ST Elevation Myocardial Infarction; Survival Rate; Thromboembolism; Ticlopidine; Time Factors; United States | 2016 |
3 other study(ies) available for paclitaxel and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; ST Elevation Myocardial Infarction; Treatment Outcome | 2017 |
Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2019 |
Very long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement for ST-elevation myocardial infarction: a propensity score-matched comparison.
Topics: Aged; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Forecasting; Humans; Immunosuppressive Agents; Incidence; Japan; Kaplan-Meier Estimate; Male; Paclitaxel; Postoperative Complications; Propensity Score; Retrospective Studies; Sirolimus; ST Elevation Myocardial Infarction; Survival Rate | 2017 |